Mirae Asset Global Etfs Holdings Ltd. Veracyte, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Veracyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 239,574 shares of VCYT stock, worth $8.74 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
239,574Holding current value
$8.74 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
272Shares Held
78.6MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$284 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$273 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$251 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$180 Million1.59% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT3.17MShares$116 Million0.44% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.61B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...